CompletedEarly Phase 1

Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients

United States24 participantsStarted 2022-05-25

Plain-language summary

This study explores the effects of hydrogen-rich water on alleviating the radiation-induced acute mucositis in head and neck cancer patients

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of a biopsy proven head and neck cancer, early or advanced stage, primary or recurrent tumor, * Planning to receive daily fractionated radiotherapy for over 4 weeks' duration * Karnofsky Performance Score (KPS) of at least 70 * Able to describe pain * Able to swallow food and water * Able to sign consent Exclusion Criteria: \-

What they're measuring

Number of participants who develop grade 3 oropharyngeal mucositis

Timeframe: 3 months after completing radiation therapy

Trial details

NCT IDNCT05278260

SponsorStony Brook University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-13

View on ClinicalTrials.gov More Mucositis Oral trials